11:39 PM
Login form
«  July 2023  »
Entries archive

My site

Main » 2023 » July » 05

(BUSINESS WIRE) -- SMOORE has gone from strength to strength with its pioneering Power Alpha solution - a charge-free solution offering over 6,000 puffs and consequently creating a ‘more convenient vaping experience’. Power Alpha hosts an assortment of cutting-edge technologies that addresses annoying issues faced by disposable users - a short battery life and the hassle of charging.

Power Alpha’s high-density battery, made with cutting-edge materials for both the positive and negative electrodes, achieves a larger battery capacity of 2000 mAh with the same size, a significant upgrade from typical 950 mAh batteries found in 3,000-puff devices.

What makes Power Alpha unique is its stabilized electrochemical potential, achieved by an enhanced stable Solid Electrolyte Interphase (SEI) film. This reduces the self-discharge rate significantly, making Power Alpha the industry leader in power retention. It has an exceptionally low power loss of just 1% ove ... Read more »

Views: 46 | Added by: africa-live | Date: 07.05.2023 | Comments (0)

INGELHEIM, Germany - Tuesday, 04. July 2023

Data demonstrate superiority vs. placebo in preventing generalized pustular psoriasis (GPP) flares up to 48 weeks1
Prevention of unpredictable flares addresses a high unmet patient need2,3
Results build on the EFFISAYIL™ 1 trial, which demonstrated rapid and sustained pustular and skin clearance in flaring GPP patients treated with spesolimab for 12 weeks2

(BUSINESS WIRE) -- Today, at the 25th World Congress of Dermatology (WCD), Boehringer Ingelheim presented new late-breaking data from the EFFISAYIL™ 2 trial showing that spesolimab significantly reduced the risk of GPP flares by 84% over 48 weeks compared to placebo. Furthermore, the trial with 123 patients demonstrated no flares after Week 4 of spesolimab treatment in the high dose group.1

“EFFISAYIL™ 2 is the first and largest multinational randomized clinical trial to evaluate a treatment for the prevention of GP ... Read more »

Views: 41 | Added by: africa-live | Date: 07.05.2023 | Comments (0)

lineage-logo-3.jpg (655×155)

(BUSINESS WIRE)--Lineage Logistics (“Lineage” or the “Company”), one of the leading temperature-controlled industrial REIT and integrated solutions providers worldwide, today announced the appointment of Brooke Miller as President of its Asia-Pacific region. In this role, she will oversee the Company’s operations across the region, including in Australia, New Zealand, Singapore, Sri Lanka, and Vietnam. She will report to Jeff Rivera, Lineage’s Global Chief Operating Officer.

Miller brings to Lineage a broad range of senior executive experience across P&L leadership, strategy, finance, sales, and marketing. Most recently, she led the Asia-Pacific region of Castrol (NYSE: BP), a BP-owned $2 billion global leader in high-performance lubricants for the automotive, industrial, marine, and a ... Read more »

Views: 42 | Added by: africa-live | Date: 07.05.2023 | Comments (0)

ZUG, Switzerland 
Latest data from the phase III OLYMPIA 2 trial presented at the World Congress of Dermatology (WCD) showcase rapid onset of action of nemolizumab in adult patients with prurigo nodularis, with 19.7% of patients treated with nemolizumab monotherapy achieving an itch-free state as early as week 4 after only one dose of nemolizumab1
100% of adults with prurigo nodularis have reported intense itching caused by the condition as their top complaint2
Nemolizumab is a first-in-class investigational monoclonal antibody that blocks the signaling of IL-31, widely recognized as the itch cytokine and a central mediator of inflammation and fibrosis in prurigo nodularis

(BUSINESS WIRE) -- Galderma presented the latest data from its pivotal phase III OLYMPIA 2 trial at the 25th World Congress of Dermatology (WCD) in Singapore. The results highlight the rapid onset of action of nemolizumab monotherapy in patients with prurigo nodularis, w ... Read more »

Views: 46 | Added by: africa-live | Date: 07.05.2023 | Comments (0)

Technology giant takes center stage in a new chapter of the automotive industry in Latin America with the production of electric and hybrid vehicles in Camaçari (BUSINESS WIRE) -- BYD, Build Your Dreams, a global powerhouse of technological innovation, has just confirmed an agreement to land in Bahia and start operations in three factories simultaneously – an unprecedented feat – in the Camaçari complex, 50km from Salvador. With an investment of more than R$ 3 billion, BYD establishes a historic landmark in the Brazilian automotive industry. It's not just about building vehicles. The group's ambitious mission, Cool the Earth by 1°C, is energy transition and sustainable mobility. It's an irreversible green revolution. Domestic production will allow for more competitive prices and the possibility for a car-loving population to access a modern-era consumer dream: an electric vehicle in the garage. The complex will consist of three manufacturing units. One dedicated to the production ... Read more »
Views: 54 | Added by: africa-live | Date: 07.05.2023 | Comments (0)